SARS‐CoV2 disease seen through the prism of acutely decompensated chronic kidney disease and ischemic stroke: What lesson we have learned from using prophylaxis therapy of vascular thromboembolism?
Abstract Our case underlines the tight management of antithrombotic therapy in the context of acutely decompensated chronic kidney disease, ischemic stroke, and SARS‐CoV2 infection, the development of stroke as a SARS‐CoV2 complication increase the chances of adverse outcomes that may be mitigated b...
Main Authors: | Asmaa Hazim, Jehanne Aasfara, Ilham Slassi, Bernard Canaud, Amal Haoudar, Abdelhamid Naitlhou, Chafik El Kettani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-12-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.3385 |
Similar Items
-
Thromboembolism in chronic Chagas' heart disease
by: João Carlos Braga, et al. -
VALUE OF THROMBOEMBOLIC PROPHYLAXIS IN PREVENTION OF THE THROMBOEMBOLISM IN ORTHOPEDIC SURGERY AND TRAUMATOLOGY
by: Gorana Rancic, et al.
Published: (2006-07-01) -
Thromboembolic disease - Etiological factors and diagnostic approach
by: Edis Dzino, et al.
Published: (2018-01-01) -
Risk Factors, Prophylaxis, and Treatment of Venous Thromboembolism in Congenital Heart Disease Patients
by: Michael Silvey, et al.
Published: (2017-06-01) -
Thromboembolic events in patients with inflammatory bowel disease
by: Farjah H Algahtani, et al.
Published: (2016-01-01)